Walleye Capital’s Korro Bio KRRO Stock Holding History

Walleye Capital’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$716K	Buy	+54,289	New	+$675K	﹤0.01%	2409
2025 Q3	–	Sell	-16,060	Closed	-$201K	–	4828
2025 Q2	$201K	Sell	16,060 -14,895	-48%	-$214K	﹤0.01%	3366
2025 Q1	$539K	Sell	30,955 -10,273	-25%	-$305K	﹤0.01%	2499
2024 Q4	$1.57M	Buy	+41,228	New	+$2.12M	﹤0.01%	2002
2024 Q3	–	Sell	-29,534	Closed	-$1M	–	5597
2024 Q2	$1M	Buy	+29,534	New	+$1.63M	﹤0.01%	2850
2022 Q2	–	Sell	-1,583	Closed	-$168K	–	2549
2022 Q1	$168K	Sell	1,583 -1,341	-46%	-$256K	﹤0.01%	1589
2021 Q4	$750K	Buy	2,924 +523	+22%	+$159K	0.02%	746
2021 Q3	$847K	Buy	2,401 +1,057	+79%	+$416K	0.02%	544
2021 Q2	$669K	Sell	1,344 -12	-0.9%	-$5.86K	0.02%	635
2021 Q1	$644K	Buy	+1,356	New	+$2.63M	0.04%	470

Other funds holding KRRO

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Walleye Capital's KRRO Position: Q2 2026 in Review

Walleye Capital opened a new position in Korro Bio (KRRO) in Q2 2026: 54,289 shares worth $716K. The stake represents ﹤0.01% of the portfolio and ranks #2409 among its holdings. This is a return to the name: Walleye Capital previously reported a position in KRRO as recently as Q2 2025.

Walleye Capital first reported a position in KRRO in Q1 2021 and has held it in 10 quarters since. The position peaked at $1.57M in Q4 2024. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

Walleye Capital held 54,289 shares of Korro Bio worth $716K as of Q2 2026.
Korro Bio was a new Walleye Capital position in Q2 2026.
Korro Bio made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2409 holding.
Walleye Capital first reported a position in Korro Bio in Q1 2021 and has held it in 10 quarters since.
Walleye Capital's Korro Bio position peaked at $1.57M in Q4 2024.
107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.